SME CASE STUDY: BAILEY INSTRUMENTS
The increased standards
of decontamination in the
NHS drove the growth
of the company as it
diversified into diabetes
diagnostic devices.
They developed the first accurate and calibrated monofilament
for diabetic neuropathy testing which remains a market leader.
Bailey Instruments moved into single use instrumentation
under the Susol™ brand in 2007 developing ergonomic and
innovatory designs enhancing performance and
reducing waste.
This was acknowledged with entry onto national
framework via the innovation pathway, as an early
pioneer of this process via NHS Supply Chain.
The framework has enabled further diversification into
general instrumentation and devices with the launch of a
single use ENT range this year via the NHS catalogue.
Bailey Instruments Ltd started in 1984 as a privately owned
company and remains independent to this day.
There are strong prospects for
accelerated growth in these
expanding markets with the NHS
engaging with manufacturers that
can deliver innovation, quality and
ethical supply.
As a surgical instrument manufacturer and supplier they
specialised in the podiatry sector rapidly developing a
reputation for quality, value and innovation.
To find out more visit:
www.baileyinstruments.co.uk
05
05